Meneceur, S.; Linge, A.; Meinhardt, M.; Hering, S.; Löck, S.; Bütof, R.; Krex, D.; Schackert, G.; Temme, A.; Baumann, M.;
et al. Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers 2020, 12, 871.
https://doi.org/10.3390/cancers12040871
AMA Style
Meneceur S, Linge A, Meinhardt M, Hering S, Löck S, Bütof R, Krex D, Schackert G, Temme A, Baumann M,
et al. Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers. 2020; 12(4):871.
https://doi.org/10.3390/cancers12040871
Chicago/Turabian Style
Meneceur, Sarah, Annett Linge, Matthias Meinhardt, Sandra Hering, Steffen Löck, Rebecca Bütof, Dietmar Krex, Gabriele Schackert, Achim Temme, Michael Baumann,
and et al. 2020. "Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma" Cancers 12, no. 4: 871.
https://doi.org/10.3390/cancers12040871
APA Style
Meneceur, S., Linge, A., Meinhardt, M., Hering, S., Löck, S., Bütof, R., Krex, D., Schackert, G., Temme, A., Baumann, M., Krause, M., & von Neubeck, C.
(2020). Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers, 12(4), 871.
https://doi.org/10.3390/cancers12040871